Insider Transactions Reported by 24 Insiders of Trevi Therapeutics, Inc.

Symbol
TRVI on Nasdaq
Location
New Haven, CT

Insiders trading volume in the past year

Trevi Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ali Behbahani 10%+ Owner $16,814,393 31 Dec 2025
Paul Edward Walker 10%+ Owner $16,814,393 31 Dec 2025
Scott D. Sandell 10%+ Owner $16,814,393 31 Dec 2025
FOREST BASKETT 10%+ Owner $16,814,393 31 Dec 2025
New Enterprise Associates 16, L.P. 10%+ Owner $16,814,393 31 Dec 2025
Carmen Chang 10%+ Owner $16,814,393 31 Dec 2025
Mohamad Makhzoumi 10%+ Owner $16,814,393 31 Dec 2025
Anthony A. Florence Jr. 10%+ Owner $16,814,393 31 Dec 2025
TPG GP A, LLC Former 10% Owner $7,726,264 01 Jul 2022
Peter W. Sonsini 10%+ Owner $1,916,875 11 Apr 2022
THOMAS SCIASCIA Chief Scientific Officer $1,461,062 -$17,365 -1.2% 19 Feb 2026
JENNIFER L. GOOD President & CEO, Director $1,403,365 -$34,625 -2.4% 19 Feb 2026
David P. Meeker Director $1,033,286 11 Jun 2025
Farrell Simon Chief Commercial Officer $549,820 19 Feb 2026
Lisa Delfini Chief Financial Officer $33,041 31 May 2025
Christopher Galletta Controller and Principal Accounting Officer $13,334 19 Feb 2026
DAVID C. HASTINGS Chief Financial Officer 08 Jan 2026
Michael Thomas Heffernan Director 11 Jun 2025
ANNE VANLENT Director 11 Jun 2025
Dominick Colangelo Director 11 Jun 2025
William P. Forbes Chief Development Officer 29 Jun 2022
James Cassella V. Chief Development Officer 19 Feb 2026
David J. Clark Chief Medical Officer 15 Feb 2024
Mathers Edward T. Director 11 Jun 2025

Recent Insider Transactions by Companies or Individuals for Trevi Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.